Author(s)

Doo Yun Lee¹, Joon Seok Park¹, Hae Chul Jung¹, Eun Seol Byun², Seok Jin Haam², Sung Soo Lee²

¹Department of Thoracic Cardiovascular Surgery, Bundang CHA Medical Center, CHA University, Kyunggido, Korea.
²Department of Thoracic Cardiovascular Surgery, Gangnam Severance Hospital, College of Medicine, Yonsei University, Seoul, Korea.

Lung cancer is one of the most aggressive and lethal form of cancers. Patients with far advanced lung cancer are treated by chemotherapy with or without radiotherapy. However, median survival of these patients is less than 6 months. To increase survival and quality of life for these patients, various forms of complementary treatments have been tried in clinical practices, and oncothermia is supposed to be one of the promising candidates. From May 2008 to November 2013, 4 patients with far advanced lung adenocarcinoma (stages IIIB and IV) were treated with oncothermia in addition to conventional chemotherapy at Gangnam Severance Hospital and Bundang CHA Hospital. All these patients have survived for more than 2 years.

Lung Cancer, Chemotherapy

Lee, D. , Park, J. , Jung, H. , Byun, E. , Haam, S. and Lee, S. (2015) The Outcome of the Chemotherapy and Oncothermia for Far Advanced Adenocarcinoma of the Lung: Case Reports of Four Patients. Advances in Lung Cancer, 4, 1-7. doi: 10.4236/alc.2015.41001.